Host genetics and HIV-1: the final phase?

PLoS Pathog. 2010 Oct 14;6(10):e1001033. doi: 10.1371/journal.ppat.1001033.

Abstract

This is a crucial transition time for human genetics in general, and for HIV host genetics in particular. After years of equivocal results from candidate gene analyses, several genome-wide association studies have been published that looked at plasma viral load or disease progression. Results from other studies that used various large-scale approaches (siRNA screens, transcriptome or proteome analysis, comparative genomics) have also shed new light on retroviral pathogenesis. However, most of the inter-individual variability in response to HIV-1 infection remains to be explained: genome resequencing and systems biology approaches are now required to progress toward a better understanding of the complex interactions between HIV-1 and its human host.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cohort Studies
  • Disease Progression
  • Genetic Variation / physiology
  • HIV Infections / genetics*
  • HIV Infections / pathology*
  • HIV Infections / prevention & control
  • HIV Infections / therapy
  • HIV-1 / genetics
  • HIV-1 / pathogenicity*
  • Host-Pathogen Interactions / genetics*
  • Humans
  • Infection Control
  • Models, Biological
  • Treatment Outcome